Inhalation Nasal Spray Generic Drugs

Inhalation and Nasal Spray Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

  • Rep Id : TMRGL1922
  • Published On : Jan 2016
  • No. of Pages : 100
  • Category : Pharmaceutical


1. Preface
    1.1. Report Description
    1.2. Market Segmentation
    1.3. Research Methodology

2. Executive Summary
    2.1. Global Inhalation and Nasal Spray Generic Drugs Market Revenue, 2013–2023 (US$ Mn)
    2.2. Global Inhalation and Nasal Spray Generic Drugs Market Revenue, by Drug Class, 2014 (US$ Mn)
    2.3. Global Inhalation and Nasal Spray Generic Drugs Market Revenue, by Medical Indication, 2014 (US$ Mn)
    2.4. Global Market Share by Geography, 2014 and 2023 (Value %)
    2.5. Inhalation and Nasal Spray Generic Drugs Market Snapshot

3. Global Inhalation and Nasal Spray Generic Drugs Market – Industry Analysis
    3.1. Introduction
    3.2. Drivers
          3.2.1. Rise in incidence of asthma, COPD, and other respiratory diseases to provide an impetus for growth
          3.2.2. Low cost involved with generic prescription drugs
    3.3. Restraints
          3.3.1. Stringent regulatory policies for generic drugs in developing countries
    3.1. Opportunities
          3.1.1. Patent expiry of blockbuster drugs would provide new opportunities for generic drug manufacturers
    3.2. Market Attractiveness Analysis – Inhalation and Nasal Spray Generic Drugs Market, By Drug Class
    3.3. Market Attractiveness Analysis – Inhalation and Nasal Spray Generic Drugs Market, By Geography
    3.4. Company Market Share – Inhalation and Nasal Spray Generic Drugs Market (2014) (%) 
    3.5. Patient Pool Analysis, by Medical Indication
    3.6. Regulatory Framework for U.S.
    3.7. Regulatory Framework for Europe

4. Market Segmentation – By Drug Class
    4.1. Introduction
    4.2. Global Corticosteroids Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.2.1. Global Fluticasone Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.2.2. Global Budesonide Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.2.3. Global Beclomethasone Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.2.4. Global Flunisolide Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.2.5. Global Other Corticosteroids Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
    4.3. Global Bronchodilators Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.3.1. Global Albuterol Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.3.2. Global Epinephrine Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.3.3. Global Other Bronchodilators Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
    4.4. Global Antihistamines Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
    4.5. Global Combinations Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.5.1. Global Salmeterol/Fluticasone Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.5.2. Global Formoterol/Budesonide Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.5.3. Global Azelastine/Benzalkonium Chloride Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.5.4. Global Other Combination Drugs Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
    4.6. Global Decongestant Sprays Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.6.1. Global Phenylephrine Hydrochloride Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)
          4.6.2. Global Oxymetazoline Hydrochloride Market for Inhalation and Nasal Spray Generic Drugs, 2013–2023 (US$ Mn)

5. Market Segmentation – By Medical Indication
    5.1. Introduction
    5.2. Global Inhalation and Nasal Spray Generic Drugs Market for Asthma, 2013–2023 (US$ Mn)
    5.3. Global Inhalation and Nasal Spray Generic Drugs Market for COPD, 2013–2023 (US$ Mn)
    5.4. Global Inhalation and Nasal Spray Generic Drugs Market for Allergic Rhinitis, 2013–2023 (US$ Mn)
    5.5. Global Inhalation and Nasal Spray Generic Drugs Market for Other Respiratory Disorders, 2013–2023 (US$ Mn)

6. Inhalation and Nasal Spray Generic Drugs Market - Regional Analysis
    6.1. Global Inhalation and Nasal Spray Generic Drugs Market: Regional Overview
    6.2. North America Inhalation and Nasal Spray Generic Drugs Market Overview
    6.3. Europe Inhalation and Nasal Spray Generic Drugs Market Overview
    6.4. Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Overview
    6.5. Latin America Inhalation and Nasal Spray Generic Drugs Market Overview
    6.6. Middle East and North Africa Inhalation and Nasal Spray Generic Drugs Market Overview
    6.7. RoW Inhalation and Nasal Spray Generic Drugs Market Overview

7. Historical Snapshot and Current Trends

8. Company Profiles.
    8.1. Allergan plc
    8.2. Beximco Pharmaceuticals
    8.3. Cipla Ltd. 
    8.4. Mylan N.V. 
    8.5. Nephron Pharmaceuticals Corporation
    8.6. Ranbaxy Laboratories Ltd. 
    8.7. Roxane Laboratories, Inc.
    8.8. Sandoz International GmbH (Novartis AG) 
    8.9. Teva Pharmaceutical Industries Ltd.